Mexico City, Mexico
November 26 - November 28, 2009

The outcomes of researches on pathophysiology of MS and availability of new drugs with innovative mechanisms of action are changing the knowledge on the disease and will offer new management options. The aim of the Symposium is to provide participants with updates on patient selection and treatment planning in order to tailor the management according to patients and diseases characteristics.

LEARNING OBJECTIVES

By attending this Symposium, participants will be updated on:

• MS Pathophysiology and possible pharmacological targets;
• Diagnostic criteria both to differentiate MS from otheR neurodegenerative diseases and to orientate among different MS forms;
• Efficacy and safety profile of pharmacological treatments that influence the treatment choice;
• Factors influencing response to treatment;
• Criteria for treatment tailoring.

TARGET AUDIENCE

Clinicians involved in MS management and scientists involved in MS researches.